| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5650264316b0dc7be3b231ae38054722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f2ca2eead3370885163b0361502bf26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c5493886d04f1610c927c22643931f |
| publicationDate |
2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113454088-A |
| titleOfInvention |
Process for the preparation of (6S) -3- [ (4S) -4-cyano-2-oxo-pyrrolidin-1-yl ] -6-methyl-N- (3,4, 5-trifluorophenyl) -6, 7-dihydro-4H-pyrazolo [1,5-a ] pyrazine-5-carboxamide |
| abstract |
The invention relates to a method for synthesizing a compound (I), or a pharmaceutically acceptable salt thereof, for use in the prevention and treatment of viral diseases associated with or caused by hepatitis B infection in a patient. |
| priorityDate |
2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |